Author of the publication

Regular use of ivermectin as prophylaxis for COVID-19 led up to 92% reduction in COVID-19 mortality rate in a dose-response manner: results of a prospective observational study of a strictly controlled population of 88,012 subjects among 223,128 participants

, , , , , , , and . Research Gate, (2022)
DOI: 10.13140/RG.2.2.19170.61128